You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail - Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

Continuous support by Kedrion Biopharma to research and partnering patient associations

read more 
  1. Kedrion - Feature thumbnail

    EVENTS - 09-11-2017

    Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

    This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

    read more 
  2. CORPORATE - 11-07-2017

    Building Bridges: An eminent specialist diagnoses a patient in distress

    Professor Hermann Wolf treats a special case in Vienna and Kedrion pitches in

    read more 
  3. CORPORATE - 17-12-2016

    IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

    Continuous support by Kedrion Biopharma to research and partnering patient associations

    read more 
  4. CORPORATE - 24-10-2016

    Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley

    Three books of the series My First Factor Creation are now available for free download

    read more 
For more information please contact: pressoffice@kedrion.com